Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations

Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations
USA - English
Share this article
Share this article
TEL AVIV, Israel and BETHESDA, Md., May 11, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it had filed a patent application under the Patent Cooperation Treaty (PCT) for novel formulations developed for treatment of various cancer types.
Said patent application includes ample preclinical supporting data collected from in-vitro experiments performed in the company's in-house drug discovery facilities in Israel, as well as from in-vivo experiments performed on mice.

Related Keywords

Mexico ,Israel ,Mexican ,Gabriel Yariv ,Facebook Cannabicspharmaceuticals ,Instagram Cannabics ,Company On Twitter Cannabics ,Linkedin ,Ministry Of Health ,Trademark Office ,Exchange Commission ,Cannabics Pharmaceuticals ,Prnewswire Cannabics Pharmaceuticals Inc ,Cannabics Pharmaceuticals Inc ,Patent Cooperation Treaty ,Cannabics Pharmaceuticals President ,Mexican Patent ,Private Securities Litigation Reform Act ,மெக்ஸிகோ ,இஸ்ரேல் ,மெக்ஸிகன் ,சென்டர் ,அமைச்சகம் ஆஃப் ஆரோக்கியம் ,முத்திரை அலுவலகம் ,பரிமாற்றம் தரகு ,காப்புரிமை ஒத்துழைப்பு ஒப்பந்தம் ,மெக்ஸிகன் காப்புரிமை ,ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,